Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: A meta-analysis of randomised, double-blind, placebo-controlled trials

International Journal of Clinical Practice

Volumn 67, Issue 6, 2013, Pages 585-594

  Wu, D ^a   Huang, Y ^a   Gu, Y ^a   Fan, W ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE; GLUCOSAMINE SULFATE; PLACEBO;

ARTICLE; BIBLIOGRAPHIC DATABASE; COCHRANE LIBRARY; DRUG EFFICACY; EFFECT SIZE; EMBASE; HIP OSTEOARTHRITIS; HUMAN; INFORMATION RETRIEVAL; KNEE OSTEOARTHRITIS; MEDLINE; META ANALYSIS; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION;

ANALGESICS; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; GLUCOSAMINE; HUMANS; MUSCULOSKELETAL PAIN; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT FAILURE;

EID: 84878059342     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12115     Document Type: Article

References (73)

1. Hootman JM, Helmick CG,. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006; 54: 226-9. (Pubitemid 43122205)
2. Smalley WE, Ray WA, Daugherty JR, Griffin MR,. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995; 141: 539-45.
3. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16: 137-62. (Pubitemid 351222155)
4. Setnikar I, Cereda R, Pacini MA, Revel L,. Antireactive properties of glucosamine sulfate. Arzneimittelforschung 1991; 41: 157-61.
5. Bassleer C, Rovati L, Franchimont P,. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 1998; 6: 427-34. (Pubitemid 28529800)
6. Largo R, Alvarez-Soria MA, Diez-Ortego I, et al. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2003; 11: 290-8. (Pubitemid 36410882)
7. Owens S, Wagner P, Vangsness CT Jr,. Recent advances in glucosamine and chondroitin supplementation. J Knee Surg 2004; 17: 185-93.
8. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006; 354: 795-808. (Pubitemid 43290918)
9. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007; 15: 981-1000. (Pubitemid 47393443)
10. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW,. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833-40. (Pubitemid 19037656)
11. Lequesne MG,. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997; 24: 779-81. (Pubitemid 27146100)
12. Juni P, Reichenbach S, Dieppe P,. Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol 2006; 20: 721-40. (Pubitemid 44354566)
13. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG,. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004; 291: 2457-65. (Pubitemid 38669189)
14. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. (Pubitemid 26120810)
15. Schulz KF, Grimes DA,. Generation of allocation sequences in randomised trials: chance, not choice. Lancet 2002; 359: 515-9. (Pubitemid 34164304)
16. Normand SL,. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 1999; 18: 321-59.
17. Corbett J, Gu CC, Rice JP, Reich T, Province MA, Rao DC,. Power loss for linkage analysis due to the dichotomization of trichotomous phenotypes. Hum Hered 2004; 57: 21-7. (Pubitemid 38608306)
18. Follmann D, Elliott P, Suh I, Cutler J,. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 1992; 45: 769-73.
19. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58. (Pubitemid 34746062)
20. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
21. Thompson SG, Higgins JP,. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-73. (Pubitemid 34746063)
22. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
23. Haflah NHM, Jaarin K, Abdullah S, Omar M,. Palm vitamin E and glucosamine sulphate in the treatment of osteoarthritis of the knee. Saudi Med J 2009; 30: 1432-8.
24. Gruenwald J, Petzold E, Busch R, Petzold HP, Graubaum HJ,. Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis. Adv Ther 2009; 26: 858-71.
25. Crowley DC, Lau FC, Sharma P, et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. Int J Med Sci 2009; 6: 312-21.
26. Zhang WB, Zhuang CY, Li JM, Yang ZP, Chen XL,. Efficacy and safety evaluation of glucosamine hydrochloride in the treatment of osteoarthritis. Zhonghua wai ke za zhi 2007; 45: 998-1001.
27. Mehta K, Gala J, Bhasale S, et al. Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]. BMC Complement Altern Med 2007; 7: 34.
28. Qiu GX, Weng XS, Zhang K, et al. A multi-central randomized, controlled clinical trial of glucosamine hydrochloride / sulfate in the treatment of knee osteoarthritis. Natl Med J China 2005; 85: 3067-70. (Pubitemid 43140894)
29. Braham R, Dawson B, Goodman C,. The effect of glucosamine supplementation on people experiencing regular knee pain. Br J Sports Med 2003; 37: 45-9. (Pubitemid 36152802)
30. Muller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I,. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 1994; 2: 61-9. (Pubitemid 24159681)
31. Ng NT, Heesch KC, Brown WJ,. Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee: a feasibility trial. Arthritis Res Ther 2010; 12: R25.
32. Olejarova M, Svobodova R, Jarosova H, et al. Efficacy evaluation of nonpharmacological treatment (regular exercise), pharmacotherapy (glucosamine sulphate, GS Condro Forte (registered trademark)) and the combination of both methods in symptomatic osteoarthritis of the knee. Results of open, randomized, controlled study. Ceska Revmatologie 2008; 16: 153-60.
33. Vajaradul Y,. Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis. Clin Ther 1981; 3: 336-43. (Pubitemid 11110541)
34. dos Reis RP, Giacovelli G, Girolami F, Andre R, Bonazzi A, Rovati LC,. Crystalline glucosamine sulfate in the treatment of osteoarthritis: evidence of long-term cardiovascular safety from clinical trials. Open Rheumatol J 2011; 5: 69-77.
35. Scholtissen S, Bruyère O, Neuprez A, et al. Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol. Int J Clin Pract 2010; 64: 756-62.
36. Petersen SG, Saxne T, Heinegard D, et al. Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training. Osteoarthritis Cartilage 2010; 18: 34-40.
37. Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage 2008; 16: 254-60. (Pubitemid 351218188)
38. Cibere J, Thorne A, Kopec JA, et al. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers. J Rheumatol 2005; 32: 896-902. (Pubitemid 40676501)
39. Talent JM, Gracy RW,. Pilot study of oral polymeric N-acetyl-D- glucosamine as a potential treatment for patients with osteoarthritis. Clin Ther 1996; 18: 1184-90. (Pubitemid 27077122)
40. Sawitzke AD, Shi H, Finco MF, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 2008; 58: 3183-91.
41. Rozendaal RM, Uitterlinden EJ, van Osch GJ, et al. Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial. Osteoarthritis Cartilage 2009; 17: 427-32.
42. Rovati LC, Pavelka K, Giacovelli G, Reginster JY,. Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent osteoarthritis structure-modifying drug trials. Osteoarthritis Cartilage 2006; 14 (Suppl. 1): 14-8. (Pubitemid 43899395)
43. Pavelka K, Bruyere O, Rovati LC, Olejarova M, Giacovelli G, Reginster JY,. Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure-modifying drug trials. Osteoarthritis Cartilage 2003; 11: 730-7. (Pubitemid 37184491)
44. Kawasaki T, Kurosawa H, Ikeda H, et al. Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial. J Bone Miner Metab 2008; 26: 279-87. (Pubitemid 351677833)
45. Messier SP, Mihalko S, Loeser RF, et al. Glucosamine/chondroitin combined with exercise for the treatment of knee osteoarthritis: a preliminary study. Osteoarthritis Cartilage 2007; 15: 1256-66. (Pubitemid 350029043)
46. Das A Jr, Hammad TA,. Efficacy of a combination of FCHG49(TM) glucosamine hydrochloride, TRH122(TM) low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 2000; 8: 343-50.
47. Sawitzke AD, Shi H, Finco MF, et al. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-Year results from GAIT. Ann Rheum Dis 2010; 69: 1459-64.
48. Giordano N, Fioravanti A, Papakostas P, Montella A, Giorgi G, Nuti R,. The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Curr Ther Res Clin Exp 2009; 70: 185-96.
49. Rozendaal RM, Koes BW, Van Osch GJVM, et al. Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med 2008; 148: 268-77. (Pubitemid 351665485)
50. Frestedt JL, Walsh M, Kuskowski MA, Zenk JL,. A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial. Nutr J 2008; 7: 9.
51. Herrero-Beaumont G, Roman Ivorra JA, Trabado MDC, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 2007; 56: 555-67.
52. McAlindon T, Formica M, LaValley M, Lehmer M, Kabbara K,. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am J Med 2004; 117: 643-9. (Pubitemid 40288170)
53. Usha PR, Naidu MUR,. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Investig 2004; 24: 353-63. (Pubitemid 38858258)
54. Cibere J, Kopec JA, Thorne A, et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Care Res 2004; 51: 738-45. (Pubitemid 39372032)
55. Zenk JL, Helmer TR, Kuskowski MA,. The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: an exploratory, randomized, double-blind, placebo-controlled trial. Curr Ther Res Clin Exp 2002; 63: 430-42.
56. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC,. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002; 162: 2113-23. (Pubitemid 35168220)
57. Hughes R, Carr A,. A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology 2002; 41: 279-84. (Pubitemid 34546007)
58. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 357: 251-6. (Pubitemid 32120855)
59. Rindone JP, Hiller D, Collacott E, Nordhaugen N, Arriola G,. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West J Med 2000; 172: 91-4.
60. Houpt JB, McMillan R, Wein C, Paget-Dellio SD,. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999; 26: 2423-30. (Pubitemid 29528986)
61. Reichelt A, Forster KK, Fischer M, Rovati LC, Setnikar I,. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study. Arzneimittel-Forschung/Drug Res 1994; 44: 75-80. (Pubitemid 24036884)
62. Noack W, Fischer M, Forster KK, Rovati LC, Setnikar I,. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 1994; 2: 51-9. (Pubitemid 24159680)
63. Pujalte JM, Llavore EP, Ylescupidez FR,. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin 1980; 7: 110-14. (Pubitemid 11161038)
64. Towheed T, Maxwell L, Anastassiades TP, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005: Issue 2. Art. No.: CD002946.
65. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG,. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int 2010; 30: 357-63.
66. Vlad SC, LaValley MP, McAlindon TE, Felson DT,. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum 2007; 56: 2267-77. (Pubitemid 47173575)
67. Poolsup N, Suthisisang C, Channark P, Kittikulsuth W,. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann Pharmacother 2005; 39: 1080-7. (Pubitemid 40695976)
68. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin M, Reginster JY,. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003; 163: 1514-22. (Pubitemid 36835094)
69. McAlindon TE, La Valley MP, Gulin JP, Felson DT,. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. J Am Med Assoc 2000; 283: 1469-75. (Pubitemid 30151826)
70. Reginster JY,. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. Arthritis Rheum 2007; 56: 2105-10.
71. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-13. (Pubitemid 28380142)
72. Schulz KF, Chalmers I, Hayes RJ, Altman DG,. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
73. Wandel S, Juni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010; 341: c4675.